Richard B. Gearry

29.6k total citations · 1 hit paper
311 papers, 9.5k citations indexed

About

Richard B. Gearry is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Richard B. Gearry has authored 311 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Genetics, 116 papers in Epidemiology and 97 papers in Surgery. Recurrent topics in Richard B. Gearry's work include Inflammatory Bowel Disease (148 papers), Microscopic Colitis (95 papers) and Gastrointestinal motility and disorders (46 papers). Richard B. Gearry is often cited by papers focused on Inflammatory Bowel Disease (148 papers), Microscopic Colitis (95 papers) and Gastrointestinal motility and disorders (46 papers). Richard B. Gearry collaborates with scholars based in New Zealand, Australia and United States. Richard B. Gearry's co-authors include Murray L. Barclay, Andrew S. Day, Christopher Frampton, B. A. Chapman, Peter G. Gibson, Peter M. Irving, Andrew McCombie, Michael J. Burt, Frank Frizelle and Martin A. Kennedy and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Richard B. Gearry

297 papers receiving 9.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry

2020 454 citations Richard B. Gearry, Gilaad G. Kaplan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard B. Gearry New Zealand	52	4.5k	3.2k	2.5k	1.5k	1.3k	311	9.5k
James O. Lindsay United Kingdom	47	5.4k 1.2×	3.8k 1.2×	2.4k 1.0×	1.3k 0.8×	1.5k 1.1×	215	9.2k
Hamed Khalili United States	47	4.2k 0.9×	4.0k 1.2×	2.1k 0.8×	1.1k 0.7×	1.8k 1.4×	220	8.2k
Millie D. Long United States	45	4.6k 1.0×	3.8k 1.2×	2.3k 0.9×	1.4k 0.9×	724 0.5×	271	8.1k
Tine Jess Denmark	57	6.7k 1.5×	5.0k 1.5×	3.1k 1.3×	809 0.5×	1.6k 1.2×	212	11.2k
Rupert W. Leong Australia	51	3.6k 0.8×	3.0k 0.9×	3.0k 1.2×	1.3k 0.8×	2.2k 1.6×	336	9.6k
Athos Bousvaros United States	46	4.1k 0.9×	3.9k 1.2×	2.0k 0.8×	842 0.6×	2.2k 1.6×	159	9.8k
David G. Binion United States	59	4.9k 1.1×	5.7k 1.8×	3.5k 1.4×	1.5k 1.0×	1.8k 1.3×	327	12.2k
Michael D. Kappelman United States	51	5.6k 1.3×	4.6k 1.4×	4.2k 1.7×	1.3k 0.8×	709 0.5×	282	11.6k
Hans Herfarth United States	55	4.7k 1.1×	4.2k 1.3×	3.0k 1.2×	1.1k 0.7×	3.1k 2.3×	264	12.1k
Stephan R. Vavricka Switzerland	50	5.4k 1.2×	4.3k 1.3×	3.0k 1.2×	836 0.6×	2.2k 1.6×	240	11.0k

Countries citing papers authored by Richard B. Gearry

Since Specialization

Citations

This map shows the geographic impact of Richard B. Gearry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Gearry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Gearry more than expected).

Fields of papers citing papers by Richard B. Gearry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Gearry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Gearry. The network helps show where Richard B. Gearry may publish in the future.

Co-authorship network of co-authors of Richard B. Gearry

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Gearry. A scholar is included among the top collaborators of Richard B. Gearry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Gearry. Richard B. Gearry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Deren, et al.. (2025). Plasma Calprotectin and Myeloperoxidase as Biomarkers in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(11). 3003–3010. 2 indexed citations

Solitano, Virginia, Çharles N. Bernstein, Iris Dotan, et al.. (2025). Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nature Reviews Gastroenterology & Hepatology. 22(6). 438–452. 5 indexed citations

Day, Andrew S., et al.. (2024). Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target. Alimentary Pharmacology & Therapeutics. 60(9). 1176–1199. 11 indexed citations

Maggo, Jasjot, Catherine Wall, Simone Bayer, et al.. (2024). Effects of Defatted Rice Bran–Fortified Bread on the Gut Microbiota Composition of Healthy Adults With Low Dietary Fiber Intake: Protocol for a Crossover Randomized Controlled Trial. JMIR Research Protocols. 13. e59227–e59227. 2 indexed citations

Maggo, Jasjot, et al.. (2024). Dietary fibre intakes of two cohorts of New Zealand adults with and without constipation. Proceedings of The Nutrition Society. 83(OCE1). 1 indexed citations

Siegel, Corey A., Victoria Rai, An Outtier, et al.. (2024). Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials. Journal of Crohn s and Colitis. 18(12). 1967–1975. 1 indexed citations

Frampton, Chris, et al.. (2024). Comparison of Fecal Calprotectin and Myeloperoxidase in Predicting Outcomes in Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 31(1). 28–36. 17 indexed citations

Wilkinson, Tim, et al.. (2024). A systematic review and meta-analysis of the dietary fiber menu provision and consumption for older adults living in residential care facilities. American Journal of Clinical Nutrition. 120(2). 431–441. 3 indexed citations

Wall, Catherine, et al.. (2023). The Low FODMAP Diet for Children with Inflammatory Bowel Disease and Overlapping Functional Gastrointestinal Symptoms – a Case Series. 3(2). 1–6. 3 indexed citations

10.

Mortlock, Sally, Anton Lord, Grant W. Montgomery, et al.. (2022). An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis. Journal of Crohn s and Colitis. 17(2). 277–288. 5 indexed citations

11.

Wall, Catherine, et al.. (2021). What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea?. Nutrients. 13(5). 1393–1393. 6 indexed citations

12.

Wall, Catherine, et al.. (2020). Adherence to exclusive enteral nutrition by adults with active Crohn’s disease is associated with conscientiousness personality trait: a sub‐study. Journal of Human Nutrition and Dietetics. 33(6). 752–757. 16 indexed citations

13.

Skidmore, Paula, Catherine Wall, Tim Wilkinson, et al.. (2020). A Low FODMAP Diet Is Nutritionally Adequate and Therapeutically Efficacious in Community Dwelling Older Adults with Chronic Diarrhoea. Nutrients. 12(10). 3002–3002. 16 indexed citations

14.

Young, Wayne, et al.. (2020). Increasing Evidence That Irritable Bowel Syndrome and Functional Gastrointestinal Disorders Have a Microbial Pathogenesis. Frontiers in Cellular and Infection Microbiology. 10. 468–468. 76 indexed citations

15.

Frampton, Christopher, et al.. (2018). A Pilot Study of the Effect of Green Kiwifruit on Human Intestinal Fermentation Measured by Hydrogen and Methane Breath Testing. Journal of Medicinal Food. 21(12). 1295–1298. 7 indexed citations

16.

Lopez, Robert, et al.. (2017). Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation. 2017. 1–9. 12 indexed citations

17.

Wright, Emily K., Michael A. Kamm, Peter De Cruz, et al.. (2016). Comparison of Fecal Inflammatory Markers in Crohnʼs Disease. Inflammatory Bowel Diseases. 22(5). 1086–1094. 19 indexed citations

18.

Julsgaard, Mette, Lisbet Ambrosius Christensen, Peter G. Gibson, et al.. (2014). Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study). United European Gastroenterology Journal. 29. 117–118. 1 indexed citations

19.

Doecke, James D., Lisa A. Simms, Zhen Zhao, et al.. (2013). Genetic Susceptibility in IBD. Inflammatory Bowel Diseases. 19(2). 240–245. 35 indexed citations

20.

Petermann, Ivonne, Christopher M. Triggs, Claudia Hüebner, et al.. (2009). Mushroom intolerance: a novel diet–gene interaction in Crohn's disease. British Journal Of Nutrition. 102(4). 506–508. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact